Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series

PURPOSE: COVID-19 patients on anti-CD20 treatment can suffer a delayed viral clearance and worse clinical outcome. We aim to present our experience with remdesivir treatment in anti-CD20-treated patients with prolonged symptoms, a patient population for which no data from randomized controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Rüfenacht, Susanne, Gantenbein, Pascal, Boggian, Katia, Flury, Domenica, Kern, Lukas, Dollenmaier, Günter, Kohler, Philipp, Albrich, Werner C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010446/
https://www.ncbi.nlm.nih.gov/pubmed/35426564
http://dx.doi.org/10.1007/s15010-022-01821-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010446/
https://www.ncbi.nlm.nih.gov/pubmed/35426564
http://dx.doi.org/10.1007/s15010-022-01821-y

Ejemplares similares